ZVSA - ZyVersa Therapeutics, Inc.

0.582
-0.035   -6.082%

Share volume: 92,321
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.04
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
14%
Profitability 0%
Dept financing 42%
Liquidity 22%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.43%
1 Month
-38.09%
3 Months
-50.68%
6 Months
-75.13%
1 Year
-92.06%
2 Year
-99.07%
Key data
Stock price
$0.58
P/E Ratio 
N/A
DAY RANGE
$0.55 - $0.62
EPS 
-$7.84
52 WEEK RANGE
$0.55 - $8.05
52 WEEK CHANGE
-$91.89
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
1.029 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
0.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$80,177
AVERAGE 30 VOLUME 
$120,200
Company detail
CEO: Daniel J. O'Connor
Region: US
Website: lsprhealth.com
Employees: 2
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Larkspur Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.

Recent news
loading